Clinical Trials Directory

Trials / Completed

CompletedNCT04085380

Digestive Colonisation by Highly Resistant Bacteria (CODBAHRE)

Identification of New Highly Antibiotic-resistant Bacteria Carriage Risk Factors to Optimize the Detection and Medical Care for Carriers Patients

Status
Completed
Phase
Study type
Observational
Enrollment
2,396 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to identify in hospitalized patients, the risk factors associated with the digestive colonisation by emergent extensively drug-resistant bacteria (eXDR), to optimize their detection and the medical care for carriers these patients

Detailed description

CODBAHRE is a french, regional study, involving 9 centers. Recruitment will take place in all the departments of the centers involved under the supervision of the Infection Control Team. All patients hospitalized more than 24 hours, on a given day are eligible for the protocol, except the patients unable to answer the questionnaire. After collecting the non-opposition of the patient, patients will be screened by rectal swab and a questionnaire will be completed. Each sample will be analyzed to detect eXDR carrying patients. The carrying patients will be followed during 6 months to estimate the proportion of the population which developped a bacterial infection. This information will be collected by a retrospective telephone survey of carrying patients.

Conditions

Timeline

Start date
2019-09-16
Primary completion
2020-01-16
Completion
2020-07-10
First posted
2019-09-11
Last updated
2020-10-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04085380. Inclusion in this directory is not an endorsement.